⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Shelli FarhadianMD, PHD

Infectious Disease · New Haven, CT 06510

NPI: 1104191311

Share:

36

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peersElevated cost per beneficiaryHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

99

Total Claims

$69K

Drug Cost

16

Beneficiaries

$4,314

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 5,387 Infectious Disease providers

-46%

Cost per patient vs peers

$4,314 vs $8,010 avg

+104%

Brand preference vs peers

43.4% vs 21.3% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

14.1%

Opioid Rate

14

Opioid Claims

$5,776

Opioid Cost

78.6%

Long-Acting Rate

Brand vs Generic

57% generic

Brand: 43 claims · $67K

Generic: 56 claims · $1,721

Patient Profile

69

Avg Age

Female

2.14

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About